Saoussen Chouchene
University of Monastir · Tunisia
Editorial leadership for International Journal of Blood Transfusion ISSN 3070-1937
Research interests
- Hematology
- Hemostasis
- Immunohematology
Biography
Saoussen Chouchene is affiliated with the University of Monastir, where her research focuses on pharmacogenetics and clinical outcomes in transplant medicine. Her work examines the genetic determinants of drug response and adverse events in patient populations, with particular emphasis on immunosuppressive therapy. Her most-cited publication, "The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events" (2024), investigates the relationship between genetic variation and clinically significant complications in renal transplant recipients receiving tacrolimus. Her contributions advance the understanding of personalized medicine approaches in transplantation and the optimization of therapeutic regimens based on pharmacogenetic profiles.
Selected publications
- The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events 2024 cited 6×
- Single nucleotide polymorphisms of SCN5A and SCN10A genes increase the risk of ventricular arrhythmias during myocardial infarction 2020 cited 6×
- Are Healthcare Professionals Adequately Trained for Safe Blood Transfusions? Targeted Training to Bridge Knowledge Gaps 2024 cited 1×
- Association of Cyp2c19 Genotype with Variability in Clopidogrel Response in Coronary Patients Recent 2025 cited 1×
- Analysis of genetic polymorphisms and mRNA expression of DRD3 and HTR2A in bruxism Recent 2026
- Study of the Genetic Polymorphisms Involved in the Response of Platelet to Clopidogrel in Coronary Patients Recent 2025
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJBT for your work?
This journal is guided by Saoussen Chouchene (University of Monastir) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.